Concepedia

Mark Ashby

MA

35

Publications

4K

Citations

24

H-Index

1986

Active since

Affiliations

St Vincent's Hospital Sydney(Current)

University of California, Los Angeles

Saint Vincent's Catholic Medical Center

City Of Hope National Medical Center

The University of Texas MD Anderson Cancer Center

Mark Ashby is an author at St Vincent's Hospital Sydney specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1986–2013

35

Publications

35

Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience

Andrew D. Seidman, Clifford A. Hudis, Mary Kathryn Pierri et al. · Journal of Clinical Oncology · 2002 · 1.5K citations

Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy

Allen P. Kaplan, Dennis K. Ledford, Mark Ashby et al. · Journal of Allergy and Clinical Immunology · 2013 · 552 citations

, , +5

Clinical Outcomes Associated with Bevacizumab-Containing Treatment of Metastatic Colorectal Cancer: The BRiTE Observational Cohort Study

Mark Kozloff, Marianne Ulcickas Yood, Jordan Berlin et al. · The Oncologist · 2009 · 307 citations · Full text

Recombinant Human Thrombopoietin Attenuates Carboplatin-Induced Severe Thrombocytopenia and the Need for Platelet Transfusions in Patients with Gynecologic Cancer

Saroj Vadhan‐Raj, Claire F. Verschraegen, Carlos Bueso-Ramos et al. · Annals of Internal Medicine · 2000 · 191 citations

Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma

Jonathan Corren, Thomas B. Casale, Yamo Deniz et al. · Journal of Allergy and Clinical Immunology · 2003 · 188 citations · Full text

, , +7

Rows per page

1–5 of 35